Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

SIU-ICUD on bladder cancer: pathology

E. Compérat, M. Babjuk, F. Algaba, M. Amin, F. Brimo, D. Grignon, D. Hansel, O. Hes, B. Malavaud, V. Reuter, T. van der Kwast,

. 2019 ; 37 (1) : 41-50. [pub] 20180914

Language English Country Germany

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19028210
E-resources Online Full text

NLK ProQuest Central from 1997-02-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-02-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-02-01 to 1 year ago

Links

PubMed 30218308
DOI 10.1007/s00345-018-2466-5
Knihovny.cz E-resources

Many changes have been made during these last years and concepts for understanding bladder cancer have evolved. We make an update with the latest findings of the WHO (World Health Organistaion) 2016, ICCR (International Collaboration on Cancer Reporting) and other official organisms and try to show the latest developments. In this document we provide new consensus guidelines and insights. We kept this document short and concise providing consensus guidelines to clinicians for the best patient care, it should be easy to understand for a non pathologists. We focussed on several burning issues, such as the anatomical and histological understanding of the bladder wall, the prognostic significance of grading and the most challenging problems in staging, we underline our needs from the clinicians such as clinical information, we further discuss the histological subtypes of bladder cancer, which is an extremely important issue in the light of molecular classifications and give prognostic insights. Furthermore, we discuss the ICCR worldwide consensus reporting, urinary cytology with the Paris system and several issues such as frozen section specimen.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028210
003      
CZ-PrNML
005      
20201019102533.0
007      
ta
008      
190813s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00345-018-2466-5 $2 doi
035    __
$a (PubMed)30218308
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Compérat, Eva $u Department of Pathology, Hopital Tenon, HUEP, Sorbonne University, Paris, France. evacomperat@gmail.com.
245    10
$a SIU-ICUD on bladder cancer: pathology / $c E. Compérat, M. Babjuk, F. Algaba, M. Amin, F. Brimo, D. Grignon, D. Hansel, O. Hes, B. Malavaud, V. Reuter, T. van der Kwast,
520    9_
$a Many changes have been made during these last years and concepts for understanding bladder cancer have evolved. We make an update with the latest findings of the WHO (World Health Organistaion) 2016, ICCR (International Collaboration on Cancer Reporting) and other official organisms and try to show the latest developments. In this document we provide new consensus guidelines and insights. We kept this document short and concise providing consensus guidelines to clinicians for the best patient care, it should be easy to understand for a non pathologists. We focussed on several burning issues, such as the anatomical and histological understanding of the bladder wall, the prognostic significance of grading and the most challenging problems in staging, we underline our needs from the clinicians such as clinical information, we further discuss the histological subtypes of bladder cancer, which is an extremely important issue in the light of molecular classifications and give prognostic insights. Furthermore, we discuss the ICCR worldwide consensus reporting, urinary cytology with the Paris system and several issues such as frozen section specimen.
650    _2
$a konsensus $7 D032921
650    _2
$a lidé $7 D006801
650    _2
$a stupeň nádoru $7 D060787
650    _2
$a staging nádorů $7 D009367
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a společnosti lékařské $7 D012955
650    _2
$a nádory močového měchýře $x patologie $7 D001749
655    _2
$a časopisecké články $7 D016428
700    1_
$a Babjuk, Marek $u Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Algaba, Ferran $u Department of Pathology, Fundacio Puigvert, Barcelona, Spain.
700    1_
$a Amin, Mahul $u Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. Department of Urology, University of Tennessee Health Science Center, Memphis, TN, USA.
700    1_
$a Brimo, Fadi $u McGill University Health Center, Glen Site, Office E4-4188, 1001 Decarie Blvd, Montréal, QC, H4A 3J1, Canada.
700    1_
$a Grignon, David J., $d -2020 $7 xx0252915 $u Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, IUH Pathology Laboratory, Indianapolis, IN, USA.
700    1_
$a Hansel, Donna $u Departments of Pathology and Urology, University of California, San Diego, CA, USA.
700    1_
$a Hes, Ondra $u Charles University and University Hospital Plzen, Pilsen, Czech Republic.
700    1_
$a Malavaud, Bernard $u Department of Urology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
700    1_
$a Reuter, Victor $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
700    1_
$a van der Kwast, Theo $u Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada.
773    0_
$w MED00004739 $t World journal of urology $x 1433-8726 $g Roč. 37, č. 1 (2019), s. 41-50
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30218308 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20201019102508 $b ABA008
999    __
$a ok $b bmc $g 1433359 $s 1066670
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 37 $c 1 $d 41-50 $e 20180914 $i 1433-8726 $m World journal of urology $n World J Urol $x MED00004739
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Archiving options